A new study suggests that a Web-based intervention could improve a cancer survivor’s cognitive function post treatment.
Cognitive impairment is a very common complaint among patients with cancer who have undergone chemotherapy. Now, a new study suggests that a Web-based intervention could improve a cancer survivor’s cognitive function.
Impaired cognitive function can impact a patient’s quality of life (QOL) and can result in depression, anxiety, and fatigue. In the absence of a documented correlation between neuropsychological testing results and cognitive symptoms, treatment remains a challenge. With the hope of addressing this issue, researchers in Australia have created a cognitive rehabilitation program: Insight.
The program was tested in 242 adult cancer survivors with a primary malignancy (not associated with the central nervous system) who had been treated with at least 3 cycles of adjuvant chemotherapy in the previous 6- to 60-month period. A complaint of persistent cognitive symptoms was a prerequisite for trial participation. While adjuvant endocrine treatments were permitted for patients with breast cancer, radiotherapy and targeted therapies had to be completed at least 3 months before participating in the study. Prior malignancy, diagnosis of an unstable psychiatric condition, and existing major cognitive disorder were grounds for exclusion.
Following a 30-minute phone consult, participants were randomly assigned (1:1) to a 15-week, home-based intervention or to standard care. Primary outcome for the trial was self-reported cognitive function (Functional Assessment of Cancer Therapy Cognitive Function [FACT-COG] perceived cognitive impairment [PCI] subscale), evaluated as the difference in function between the groups after completing a 15-week intervention (T2) and after 6 months (T3).
The researchers observed less PCI in the intervention group at T2 (P <.001), which was sustained at T3 (P <.001). At T2, significant difference in all the FACT-COG subscales were indicative of a successful intervention, the authors write. Further, levels of anxiety, depression, and fatigue were lower in the intervention group at T2, while stress was significantly lower at both time points. The intervention group also gained on QOL at the 6-month mark.
“The intervention, Insight, led to improvements in cognitive symptoms compared with standard care,” the authors conclude, “indicating that this intervention is a feasible treatment.”
Reference
Bray VJ, Dhillon HM, Bell ML, et al. Evaluation of a Web-based cognitive rehabilitation program in cancer survivors reporting cognitive symptoms after chemotherapy [published online October 28, 2016]. J Clin Oncol. doi: 10.1200/JCO.2016.67.8201.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More